CNBC
1 week ago
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.
Latest News
India's rice export ban could send decade-high prices spiking even further
1 week ago
Asia markets fall as Japan's inflation rises slightly in June
1 week ago
Biden administration calls on employers to help keep people insured as millions lose Medicaid
1 week ago
Why Tesla investors should care about Elon Musk's multiplying ventures
1 week ago
Is Ukraine's counteroffensive failing? Defense experts say the risks facing Kyiv are growing
1 week ago